Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 43

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 43
---
 those represented by Depositary
Shares), including:

| · | each person, or group of affiliated persons, that is known by us to be a beneficial owner of 5% or more   
 of Ordinary Shares (based on information in our share register and information provided by such persons); |

| · | each member of our Board of Directors; |

| · | each member of our senior management; and |

| · | all members of our Board of Directors and our senior management, taken as a group. |

Beneficial
ownership of shares is determined under rules of the SEC and generally includes any shares
over which a person exercises sole or shared voting or investment power. Except as noted
by footnote, and subject to community property laws where applicable, we believe, based upon
the information provided to us, that the persons and entities named in the table below have
sole voting and investment power with respect to all Ordinary Shares shown as beneficially
owned by them. The percentage of beneficial ownership is based upon 68,178,708,922 Ordinary
Shares outstanding as of December 1, 2025. Ordinary Shares subject to options or warrants
currently exercisable or exercisable within 60 days of December 1, 2025 are deemed to be
outstanding and beneficially owned by the person holding the options or warrants for the
purposes of computing the percentage of beneficial ownership of that person and any group
of which that person is a member, but are not deemed outstanding for the purpose of computing
the percentage of beneficial ownership for any other person. Unless otherwise indicated,
the address for each holder listed below is Biodexa Pharmaceuticals plc, 1 Caspian Point,
Caspian Way, Cardiff, CF10 4DQ, United Kingdom. All holders of Ordinary Shares, including
those shareholders listed below, have the same voting rights with respect to such shares.

| Name of Beneficial Owner                                   |     | Amount and   
 Nature       
 Of Ownership |             |     | Percent  
 of Class |   |
| Directors and Senior Management:                           |     |              |             |     |          |   |
| Ann Merchant (1)                                           |     |              |  14,400,000 |     |          | * |
| Stephen Parker (2)                                         |     |              |  28,800,000 |     |          | * |
| Stephen Stamp (3)                                          |     |              |  37,632,375 |     |          | * |